ISPOR - Evaluation of Daa (Direct-Acting Antiviral) Access Across the United States- The Interplay Between Hepatitis C Patient and Insurance Type

Full Text

Evaluation of Daa (Direct-Acting Antiviral) Access Across the United States- The Interplay Between Hepatitis C Patient and Insurance Type

Abstract

Authors

E Hautamaki J Katz A Mohammed J Deemer S Heinz EJ Baynton S Narayanan

Back to Volume 19, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now